Ferti C Injection 5000 IU

About Ferti C Injection 5000 IU

Ferti C Injection Uses

• Used for triggering ovulation after follicle stimulation in women undergoing fertility treatment
• Indicated for women with anovulatory infertility where the cause is not primary ovarian failure
• Effective in completing final egg maturation before egg retrieval in IVF cycles
• Supports treatment of male hypogonadism caused by insufficient hormone production
• Given to boys with undescended testicles as part of hormonal treatment, usually between ages 4 and 9
• Chosen as the ovulation trigger in IUI cycles after adequate follicular development is confirmed
• Approved for supporting the corpus luteum phase in controlled ovarian stimulation cycles

Ferti C Injection 5000 IU formula

Human Chorionic Gonadotropin 5000 IU per vial

Available forms

• Injection

How to use Ferti C Injection 5000 IU?

• Menotropins (HMG): Ferti C injection is given one day after the last HMG dose to complete follicle maturation; timing between the two must be precisely coordinated by the specialist
• Follicle-stimulating hormone (FSH) medicines (e.g., Gonal-F, Follistim): used before Ferti C injection in stimulation cycles; the hCG trigger must only be given when follicle size and estradiol levels are appropriate
• GnRH antagonists (e.g., cetrorelix, ganirelix): commonly used with Ferti C injection in ART cycles to prevent premature ovulation; the doctor manages the timing of both medicines together
• Clomiphene citrate: used to stimulate follicle growth before the hCG trigger; combined use increases the risk of multiple pregnancy and requires close monitoring
• Progesterone supplements: often prescribed after Ferti C injection to support the luteal phase; both medicines are usually part of the same treatment plan

Contraindications

• Allergy to human chorionic gonadotropin or any ingredient in the injection
• Primary ovarian failure, where the ovaries are unable to produce eggs at all
• Existing or confirmed pregnancy
• Hormone-sensitive cancers of the breast, uterus, ovaries, or prostate
• Ovarian cysts or enlarged ovaries not related to controlled stimulation treatment
• Uncontrolled thyroid, adrenal, or pituitary gland disorders
• Tumors of the pituitary gland or hypothalamus
• Abnormal uterine bleeding with no confirmed cause

Drug Interactions

• Menotropins (HMG): Ferti C injection is given one day after the last HMG dose to complete follicle maturation; timing between the two must be precisely coordinated by the specialist
• Follicle-stimulating hormone (FSH) medicines (e.g., Gonal-F, Follistim): used before Ferti C injection in stimulation cycles; the hCG trigger must only be given when follicle size and estradiol levels are appropriate
• GnRH antagonists (e.g., cetrorelix, ganirelix): commonly used with Ferti C injection in ART cycles to prevent premature ovulation; the doctor manages the timing of both medicines together
• Clomiphene citrate: used to stimulate follicle growth before the hCG trigger; combined use increases the risk of multiple pregnancy and requires close monitoring
• Progesterone supplements: often prescribed after Ferti C injection to support the luteal phase; both medicines are usually part of the same treatment plan

Risks and warnings

• Ovarian hyperstimulation syndrome (OHSS): A serious and potentially life-threatening risk; stop use and contact your doctor immediately if severe pelvic pain, sudden weight gain, bloating, or difficulty breathing occurs
• Multiple pregnancy: This injection increases the chance of twins or higher-order pregnancies, which carry added health risks for both the mother and babies
• Blood clot risk: HCG treatment can raise the risk of blood clots in veins or arteries; women with a history of clotting disorders need specialist assessment before starting
• Early puberty in boys: This injection can trigger early puberty signs in young boys, including voice changes, genital enlargement, and facial hair; the doctor must monitor closely throughout treatment
• Timing criticality: The injection must be given at the exact time prescribed relative to follicle maturation; incorrect timing can result in failed ovulation or empty follicle syndrome
• PCOS patients: Women with polycystic ovary syndrome face a higher risk of ovarian overstimulation and require careful monitoring of hormone levels before the injection is given
• Pregnancy: This injection must not be given to a woman who is already pregnant; it is a strict contraindication
• Liver function: Abnormal liver function test results have been reported with HCG use; patients with existing liver conditions require monitoring

Ferti C Injection Side Effects

• Injection site pain, redness, or swelling
• Headache
• Abdominal pain or cramping
• Bloating or pelvic discomfort
• Nausea and vomiting
• Breast tenderness or swelling
• Restlessness or irritability
• Fatigue
• Mild fluid retention
• Ovarian hyperstimulation syndrome (OHSS), a potentially serious condition requiring immediate medical attention
• Multiple pregnancy
• Signs of blood clot such as sudden leg pain, chest pain, or numbness on one side of the body (seek emergency care)
• Early puberty signs in boys (seek immediate medical review)
• Allergic reaction including hives, facial swelling, or difficulty breathing (seek emergency care)

Storage Conditions

• Store Ferti C injection in the refrigerator between 2°C and 8°C and never freeze it
• Keep away from direct sunlight, heat, and moisture
• Keep out of reach of children and pets